These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 28194615)
1. How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID). Kohn DB; Gaspar HB J Clin Immunol; 2017 May; 37(4):351-356. PubMed ID: 28194615 [TBL] [Abstract][Full Text] [Related]
2. Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency. Kohn DB; Hershfield MS; Puck JM; Aiuti A; Blincoe A; Gaspar HB; Notarangelo LD; Grunebaum E J Allergy Clin Immunol; 2019 Mar; 143(3):852-863. PubMed ID: 30194989 [TBL] [Abstract][Full Text] [Related]
3. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome. Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience. Scott O; Kim VH; Reid B; Pham-Huy A; Atkinson AR; Aiuti A; Grunebaum E J Clin Immunol; 2017 Aug; 37(6):582-591. PubMed ID: 28748310 [TBL] [Abstract][Full Text] [Related]
5. National experience with adenosine deaminase deficiency related SCID in Polish children. Dąbrowska-Leonik N; Piątosa B; Słomińska E; Bohynikova N; Bernat-Sitarz K; Bernatowska E; Wolska-Kuśnierz B; Kałwak K; Kołtan S; Dąbrowska A; Goździk J; Ussowicz M; Pac M Front Immunol; 2022; 13():1058623. PubMed ID: 36685585 [TBL] [Abstract][Full Text] [Related]
7. Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug. Ferrua F; Aiuti A Hum Gene Ther; 2017 Nov; 28(11):972-981. PubMed ID: 28847159 [TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency. Shaw KL; Garabedian E; Mishra S; Barman P; Davila A; Carbonaro D; Shupien S; Silvin C; Geiger S; Nowicki B; Smogorzewska EM; Brown B; Wang X; de Oliveira S; Choi Y; Ikeda A; Terrazas D; Fu PY; Yu A; Fernandez BC; Cooper AR; Engel B; Podsakoff G; Balamurugan A; Anderson S; Muul L; Jagadeesh GJ; Kapoor N; Tse J; Moore TB; Purdy K; Rishi R; Mohan K; Skoda-Smith S; Buchbinder D; Abraham RS; Scharenberg A; Yang OO; Cornetta K; Gjertson D; Hershfield M; Sokolic R; Candotti F; Kohn DB J Clin Invest; 2017 May; 127(5):1689-1699. PubMed ID: 28346229 [TBL] [Abstract][Full Text] [Related]